Variant report

Variant	nsv587484
Chromosome Location	chr21:40983133-40986120
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:90)
CpG islands
(count:611)
Chromatin interactive
region (count:3)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:90 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr21:40985244-40985498	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr21:40984949-40984971	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr21:40985549-40985749	K562	blood:	n/a	n/a
4	CHD1	chr21:40985461-40985984	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD1	chr21:40983959-40984159	H1-hESC	embryonic stem cell:	n/a	n/a
6	CHD1	chr21:40984373-40984511	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD2	chr21:40983481-40983811	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTBP2	chr21:40984082-40984890	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr21:40984700-40984850	HA-sp	spinal cord:	n/a	n/a
10	CTCF	chr21:40984780-40984930	SK-N-SH_RA	brain:	n/a	n/a
11	CTCF	chr21:40984802-40984968	MCF-7	breast:	n/a	n/a
12	CTCF	chr21:40984838-40984940	MCF-7	breast:	n/a	n/a
13	CTCF	chr21:40984800-40984950	SK-N-SH_RA	brain:	n/a	n/a
14	CTCF	chr21:40984840-40984990	HRPEpiC	eye:	n/a	n/a
15	CTCF	chr21:40984780-40984930	AG09319	gingival:	n/a	n/a
16	CTCF	chr21:40984860-40985010	AG04449	skin:	n/a	n/a
17	CTCF	chr21:40984820-40984970	HBMEC	blood vessel:	n/a	n/a
18	CTCF	chr21:40984299-40984374	Fibrobl	skin:	n/a	n/a
19	CTCF	chr21:40984820-40984970	WERI-Rb-1	eye:	n/a	n/a
20	CTCF	chr21:40984780-40984930	AG04449	skin:	n/a	n/a
21	CTCF	chr21:40984800-40984950	RPTEC	kidney:	n/a	n/a
22	CTCF	chr21:40984220-40984370	AG09309	skin:	n/a	n/a
23	CTCF	chr21:40984878-40984916	MCF-7	breast:	n/a	n/a
24	CTCF	chr21:40984780-40984930	Caco-2	colon:	n/a	n/a
25	CTCF	chr21:40984836-40984932	MCF-7	breast:	n/a	n/a
26	CTCF	chr21:40984800-40984950	H1-hESC	embryonic stem cell:	n/a	n/a
27	CTCF	chr21:40984840-40984990	HEK293	kidney:	n/a	n/a
28	E2F6	chr21:40983369-40984008	H1-hESC	embryonic stem cell:	n/a	n/a
29	GATA3	chr21:40985802-40986091	MCF-7	breast:	n/a	n/a
30	GATA3	chr21:40985350-40986224	MCF-7	breast:	n/a	n/a
31	GTF2F1	chr21:40984357-40984543	H1-hESC	embryonic stem cell:	n/a	n/a
32	GTF2F1	chr21:40984759-40984940	H1-hESC	embryonic stem cell:	n/a	n/a
33	HA-E2F1	chr21:40985191-40985843	MCF-7	breast:	n/a	n/a
34	JUN	chr21:40982614-40983146	H1-hESC	embryonic stem cell:	n/a	n/a
35	JUND	chr21:40984189-40984902	H1-hESC	embryonic stem cell:	n/a	n/a
36	JUND	chr21:40983623-40983733	H1-hESC	embryonic stem cell:	n/a	n/a
37	JUND	chr21:40984850-40984987	H1-hESC	embryonic stem cell:	n/a	n/a
38	JUND	chr21:40982557-40983221	H1-hESC	embryonic stem cell:	n/a	n/a
39	KAP1	chr21:40985260-40985856	HEK293	kidney:	n/a	n/a
40	MAX	chr21:40984615-40985057	H1-hESC	embryonic stem cell:	n/a	n/a
41	MAX	chr21:40984561-40985053	H1-hESC	embryonic stem cell:	n/a	n/a
42	MAX	chr21:40983420-40983888	H1-hESC	embryonic stem cell:	n/a	chr21:40983644-40983653 chr21:40983642-40983650 chr21:40983643-40983653 chr21:40983645-40983652
43	MAX	chr21:40983497-40983928	H1-hESC	embryonic stem cell:	n/a	chr21:40983644-40983653 chr21:40983642-40983650 chr21:40983643-40983653 chr21:40983645-40983652
44	MAX	chr21:40983392-40983880	H1-hESC	embryonic stem cell:	n/a	chr21:40983644-40983653 chr21:40983642-40983650 chr21:40983643-40983653 chr21:40983645-40983652
45	MAX	chr21:40985494-40985779	H1-hESC	embryonic stem cell:	n/a	n/a
46	MYC	chr21:40984334-40984344	MCF-7	breast:	n/a	n/a
47	MYC	chr21:40985594-40985684	MCF-7	breast:	n/a	n/a
48	MYC	chr21:40983632-40983932	H1-hESC	embryonic stem cell:	n/a	chr21:40983644-40983653 chr21:40983642-40983650 chr21:40983643-40983653 chr21:40983645-40983652
49	NRF1	chr21:40984316-40984388	H1-hESC	embryonic stem cell:	n/a	n/a
50	NRF1	chr21:40984575-40985199	SK-N-SH	brain:	n/a	chr21:40984921-40984930 chr21:40984814-40984823

(count:611 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:40985406-40985456	HRCEpiC	kidney:	n/a
2	chr21:40985406-40985456	HRCEpiC	kidney:	n/a
3	chr21:40984777-40984827	U87	brain:	n/a
4	chr21:40984777-40984827	SAEC	small airway:	n/a
5	chr21:40984700-40984750	HAEpiC	amniotic membrane:	n/a
6	chr21:40985406-40985456	HCPEpiC	choroid plexus:	n/a
7	chr21:40985406-40985456	BE2_C	brain:	n/a
8	chr21:40984886-40984936	K562	blood:	n/a
9	chr21:40984886-40984936	SK-N-SH	brain:	n/a
10	chr21:40984610-40984660	MCF10A-Er-Src	breast:	n/a
11	chr21:40984886-40984936	MCF10A-Er-Src	breast:	n/a
12	chr21:40984760-40984810	HEEpiC	esophagus:	n/a
13	chr21:40984700-40984750	GM06990	blood:	n/a
14	chr21:40984886-40984936	BE2_C	brain:	n/a
15	chr21:40984763-40984813	PANC-1	pancreas:	n/a
16	chr21:40985406-40985456	HPAEpiC	pulmonary alveolar:	n/a
17	chr21:40984886-40984936	HMEC	breast:	n/a
18	chr21:40984553-40984603	HMEC	breast:	n/a
19	chr21:40985406-40985456	HMEC	breast:	n/a
20	chr21:40984780-40984830	HIPEpiC	eye:	n/a
21	chr21:40985387-40985437	K562	blood:	n/a
22	chr21:40984553-40984603	LNCaP	prostate:	n/a
23	chr21:40984780-40984830	IMR90	lung:	fetal
24	chr21:40984777-40984827	HCT-116	colon:	n/a
25	chr21:40984700-40984750	HNPCEpiC	eye:	n/a
26	chr21:40985387-40985437	GM12891	blood:	n/a
27	chr21:40984886-40984936	HRCEpiC	kidney:	n/a
28	chr21:40984610-40984660	HNPCEpiC	eye:	n/a
29	chr21:40984700-40984750	SK-N-SH_RA	brain:	n/a
30	chr21:40984780-40984830	SK-N-MC	brain:	n/a
31	chr21:40984760-40984810	HRE	kidney:	n/a
32	chr21:40984780-40984830	NHBE	bronchial:	n/a
33	chr21:40985406-40985456	HRPEpiC	eye:	n/a
34	chr21:40984610-40984660	U87	brain:	n/a
35	chr21:40984763-40984813	Hela-S3	cervix:	n/a
36	chr21:40985387-40985437	HRE	kidney:	n/a
37	chr21:40984760-40984810	U87	brain:	n/a
38	chr21:40984763-40984813	HEEpiC	esophagus:	n/a
39	chr21:40984763-40984813	GM12892	blood:	n/a
40	chr21:40984777-40984827	IMR90	lung:	fetal
41	chr21:40984763-40984813	MCF10A-Er-Src	breast:	n/a
42	chr21:40984763-40984813	BE2_C	brain:	n/a
43	chr21:40984700-40984750	HCPEpiC	choroid plexus:	n/a
44	chr21:40984886-40984936	PrEC	prostate:	n/a
45	chr21:40984886-40984936	NHDF-neo	bronchial:	n/a
46	chr21:40985387-40985437	AG09309	skin:	n/a
47	chr21:40984886-40984936	AG09319	gingival:	n/a
48	chr21:40984886-40984936	GM19239	blood:	n/a
49	chr21:40984610-40984660	H1-hESC	embryonic stem cell:	embryo
50	chr21:40984763-40984813	H1-hESC	embryonic stem cell:	embryo

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:40985808..40987789-chr21:41000169..41002424,2	MCF-7	breast:
2	chr21:40950925..40952824-chr21:40985213..40987161,2	MCF-7	breast:
3	chr21:40982969..40984570-chr21:40986006..40988233,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C21orf88-1	chr21:40984224-40984749	NR_026543
2	lnc-C21orf88-1	chr21:40984224-40984749	NR_026542
3	lnc-C21orf88-1	chr21:40984224-40984994	NONHSAT082200

No data

Variant related genes	Relation type
C21orf88	TF binding region
C21orf88	CpG island
ENSG00000184809	chromatin interactions
ENSG00000225330	chromatin interactions

Extended variants
information (count: 98 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:98 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs189557288	chr21:40983149-40983150	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs371512417	chr21:40983155-40983156	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs375235530	chr21:40983161-40983162	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs558091468	chr21:40983174-40983175	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs578173639	chr21:40983288-40983289	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs534208592	chr21:40983324-40983325	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs554073807	chr21:40983359-40983360	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs527547839	chr21:40983465-40983466	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs114766187	chr21:40983479-40983480	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs397867665	chr21:40983497-40983498	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs112219111	chr21:40983540-40983541	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs576075771	chr21:40983542-40983543	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs111441453	chr21:40983552-40983553	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs113876108	chr21:40983582-40983583	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs539691865	chr21:40983621-40983622	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs545151905	chr21:40983773-40983774	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs138652672	chr21:40983779-40983780	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs183265416	chr21:40983804-40983805	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs563438598	chr21:40983867-40983868	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs547709366	chr21:40984048-40984049	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs561205818	chr21:40984079-40984080	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs118064583	chr21:40984118-40984119	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs565161106	chr21:40984119-40984120	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs529264805	chr21:40984125-40984126	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs187952036	chr21:40984148-40984149	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs370598876	chr21:40984197-40984198	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs374637226	chr21:40984278-40984279	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
28	rs141178643	chr21:40984279-40984280	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
29	rs371204587	chr21:40984280-40984281	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
30	rs74789072	chr21:40984309-40984310	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
31	rs190864220	chr21:40984323-40984324	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
32	rs371688177	chr21:40984343-40984344	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs571728450	chr21:40984359-40984360	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
34	rs150259552	chr21:40984399-40984400	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs139042793	chr21:40984442-40984443	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
36	rs539486727	chr21:40984445-40984446	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
37	rs113833591	chr21:40984446-40984447	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
38	rs567621094	chr21:40984452-40984453	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs77926611	chr21:40984509-40984510	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs555898624	chr21:40984519-40984520	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs576022941	chr21:40984561-40984562	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs376699614	chr21:40984574-40984575	Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs544755540	chr21:40984609-40984610	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
44	rs561449867	chr21:40984614-40984615	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs183583461	chr21:40984652-40984653	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs558664236	chr21:40984653-40984654	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs75427946	chr21:40984703-40984704	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs369772690	chr21:40984712-40984713	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs541237612	chr21:40984723-40984724	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs373133724	chr21:40984790-40984791	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Down syndrome	20877625	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Prostate cancer	21147910	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Breast cancer	22522925	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD
Cancer	20164919	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:40970800-40984600	Weak transcription	Right Atrium	heart
2	chr21:40976800-40983200	Weak transcription	Brain Anterior Caudate	brain
3	chr21:40981000-40983600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
4	chr21:40981400-40983200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr21:40981600-40984200	Enhancers	Stomach Mucosa	stomach
6	chr21:40981800-40983400	Enhancers	Fetal Intestine Large	intestine
7	chr21:40982000-40984200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr21:40982200-40983400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr21:40982200-40983400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr21:40982400-40983600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
11	chr21:40982400-40983600	Bivalent Enhancer	Fetal Intestine Small	intestine
12	chr21:40982400-40984200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr21:40982400-40984200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr21:40982400-40984400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
15	chr21:40982600-40983200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr21:40982600-40983200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
17	chr21:40982600-40983200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr21:40982600-40983200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
19	chr21:40982600-40983200	Enhancers	Placenta Amnion	Placenta Amnion
20	chr21:40982600-40983400	Enhancers	NH-A	brain
21	chr21:40982600-40983600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr21:40982600-40984000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
23	chr21:40982600-40984200	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
24	chr21:40982800-40983800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr21:40982800-40985200	Active TSS	Rectal Mucosa Donor 31	rectum
26	chr21:40982800-40986000	Active TSS	ES-I3 Cell Line	embryonic stem cell
27	chr21:40982800-40986400	Active TSS	H9 Cell Line	embryonic stem cell
28	chr21:40983000-40983200	Flanking Active TSS	H1 Cell Line	embryonic stem cell
29	chr21:40983000-40983200	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
30	chr21:40983000-40983200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
31	chr21:40983000-40983400	Weak transcription	Pancreas	Pancrea
32	chr21:40983000-40983600	Enhancers	Cortex derived primary cultured neurospheres	brain
33	chr21:40983200-40983400	Active TSS	H1 Cell Line	embryonic stem cell
34	chr21:40983200-40983400	Flanking Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
35	chr21:40983200-40983600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr21:40983200-40983600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr21:40983200-40983800	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr21:40983200-40984000	Active TSS	HUES64 Cell Line	embryonic stem cell
39	chr21:40983200-40984000	Bivalent Enhancer	Fetal Stomach	stomach
40	chr21:40983200-40984600	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
41	chr21:40983200-40985600	Active TSS	iPS-15b Cell Line	embryonic stem cell
42	chr21:40983200-40987600	Active TSS	Brain Anterior Caudate	brain
43	chr21:40983400-40983600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
44	chr21:40983400-40983600	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr21:40983400-40983600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
46	chr21:40983400-40983600	Bivalent Enhancer	Fetal Intestine Large	intestine
47	chr21:40983400-40984000	Flanking Active TSS	H1 Cell Line	embryonic stem cell
48	chr21:40983400-40984200	Bivalent Enhancer	Fetal Brain Female	brain
49	chr21:40983400-40984400	Enhancers	Breast Myoepithelial Primary Cells	Breast
50	chr21:40983400-40984400	Bivalent Enhancer	Fetal Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links